Literature DB >> 16399490

Genistein affects the expression of genes involved in blood pressure regulation and angiogenesis in primary human endothelial cells.

R Ambra1, G Rimbach, S de Pascual Teresa, D Fuchs, U Wenzel, H Daniel, F Virgili.   

Abstract

BACKGROUND: Several lines of evidence suggest that the dietary isoflavone genistein (Gen) has beneficial effects with regard to cardiovascular disease and in particular on aspects related to blood pressure and angiogenesis. The biological action of Gen may be, at least in part, attributed to its ability to affect cell signalling and response. However, so far, most of the molecular mechanisms underlying the activity of Gen in the endothelium are unknown. METHODS AND
RESULTS: To examine the transcriptional response to 2.5 microM Gen on primary human endothelial cells (HUVEC), we applied cDNA array technology both under baseline condition and after treatment with the pro-atherogenic stimulus, copper-oxidized LDL. The alteration of the expression patterns of individual transcripts was substantiated using either RT-PCR or Northern blotting. Gen significantly affected the expression of genes encoding for proteins centrally involved in the vascular tone such as endothelin-converting enzyme-1, endothelin-2, estrogen related receptor alpha and atrial natriuretic peptide receptor A precursor. Furthermore, Gen countered the effect of oxLDL on mRNA levels encoding for vascular endothelial growth factor receptor 165, types 1 and 2.
CONCLUSIONS: Our data indicate that physiologically achievable levels of Gen change the expression of mRNA encoding for proteins involved in the control of blood pressure under baseline conditions and reduce the angiogenic response to oxLDL in the endothelium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16399490     DOI: 10.1016/j.numecd.2005.03.003

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  8 in total

Review 1.  Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

Authors:  V B Gencel; M M Benjamin; S N Bahou; R A Khalil
Journal:  Mini Rev Med Chem       Date:  2012-02       Impact factor: 3.862

Review 2.  Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs.

Authors:  Adriana Albini; Stefano Indraccolo; Douglas M Noonan; Ulrich Pfeffer
Journal:  Clin Exp Metastasis       Date:  2010-04-10       Impact factor: 5.150

3.  Identification of Estrogen-Related Receptor α Agonists in the Tox21 Compound Library.

Authors:  Caitlin Lynch; Jinghua Zhao; Ruili Huang; Noriko Kanaya; Lauren Bernal; Jui-Hua Hsieh; Scott S Auerbach; Kristine L Witt; B Alex Merrick; Shiuan Chen; Christina T Teng; Menghang Xia
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

Review 4.  Soy isoflavones and prostate cancer: a review of molecular mechanisms.

Authors:  Abeer M Mahmoud; Wancai Yang; Maarten C Bosland
Journal:  J Steroid Biochem Mol Biol       Date:  2013-12-25       Impact factor: 4.292

5.  Development of Novel Cell Lines for High-Throughput Screening to Detect Estrogen-Related Receptor Alpha Modulators.

Authors:  Christina T Teng; Jui-Hua Hsieh; Jinghua Zhao; Ruili Huang; Menghang Xia; Negin Martin; Xiaohua Gao; Darlene Dixon; Scott S Auerbach; Kristine L Witt; B Alex Merrick
Journal:  SLAS Discov       Date:  2017-01-31       Impact factor: 3.341

Review 6.  Soy and breast cancer: focus on angiogenesis.

Authors:  Lenka Varinska; Peter Gal; Gabriela Mojzisova; Ladislav Mirossay; Jan Mojzis
Journal:  Int J Mol Sci       Date:  2015-05-22       Impact factor: 5.923

Review 7.  ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities.

Authors:  Natalia Zamorano Cuervo; Nathalie Grandvaux
Journal:  Elife       Date:  2020-11-09       Impact factor: 8.140

Review 8.  Molecular Changes Underlying Genistein Treatment of Wound Healing: A Review.

Authors:  Matúš Čoma; Veronika Lachová; Petra Mitrengová; Peter Gál
Journal:  Curr Issues Mol Biol       Date:  2021-05-17       Impact factor: 2.976

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.